Tang Capital Partners Discloses Stake in Precision BioSciences

TL;DR

**Tang Capital Partners just revealed a stake in Precision BioSciences, watch for potential upside!**

AI Summary

Tang Capital Partners, LP, a Delaware-based investment firm, along with Kevin Tang and Tang Capital Management, LLC, reported a significant stake in Precision BioSciences, Inc. (NASDAQ: PBIO) as of January 24, 2024. This SC 13G filing indicates that Tang Capital Partners, LP holds 0 shares with sole voting power, but is part of a group that beneficially owns shares, suggesting a strategic, non-controlling investment. This matters to investors because it signals that a notable institutional investor sees potential value in Precision BioSciences, a company focused on biological products, which could be a positive indicator for the stock's future performance.

Why It Matters

This filing reveals a prominent investment group, Tang Capital Partners, has taken a position in Precision BioSciences, potentially signaling confidence in the company's future and attracting other investors.

Risk Assessment

Risk Level: low — This filing indicates an institutional investor has taken a position, which is generally a positive signal and not inherently risky.

Analyst Insight

A smart investor would research Tang Capital Partners' investment history and Precision BioSciences' fundamentals to understand the potential rationale behind this stake, considering it a positive signal that warrants further due diligence.

Key Numbers

• 0 — Sole Voting Power Shares (Shares with sole voting power held by Tang Capital Partners, LP as of January 24, 2024)
• January 24, 2024 — Date of Event (The date that triggered the requirement for this SC 13G filing)
• 74019P108 — CUSIP Number (Unique identifier for Precision BioSciences, Inc. common stock)

Key Players & Entities

• Tang Capital Partners, LP (company) — reporting person and investment firm
• Precision BioSciences, Inc. (company) — subject company of the filing
• Kevin Tang (person) — group member associated with the reporting entity
• Tang Capital Management, LLC (company) — group member associated with the reporting entity
• Delaware (company) — place of organization for Tang Capital Partners, LP

Forward-Looking Statements

• Precision BioSciences' stock price may see increased attention due to institutional interest. (Precision BioSciences) — medium confidence, target: Q2 2024
• Tang Capital Partners may increase their stake or engage in further shareholder activism. (Tang Capital Partners) — low confidence, target: Q4 2024

FAQ

Key Financial Figures

• $0.000005 — ame of Issuer) Common Stock, par value $0.000005 per share (Title of Class of Securiti

Filing Documents

• d125241sc13g.htm (SC 13G) — 82KB
• ex99_1.htm (EX-99.1) — 8KB
• 0001214659-24-001943.txt ( ) — 92KB

(a). Name of Issuer

Item 1(a). Name of Issuer: Precision BioSciences, Inc. (the “Issuer”)

(b). Address of Issuer’s Principal Executive Offices

Item 1(b). Address of Issuer’s Principal Executive Offices: 302 East Pettigrew Street, Suite A-100, Durham, NC 27701

(a). Name of Person Filing

Item 2(a). Name of Person Filing: This Statement on Schedule 13G (this “Statement”) is filed by Tang Capital Partners, LP (“Tang Capital Partners”); Tang Capital Management, LLC, the general partner of Tang Capital Partners (“Tang Capital Management”); and Kevin Tang, the manager of Tang Capital Management.

(b). Address of Principal Business Office or, if none, Residence

Item 2(b). Address of Principal Business Office or, if none, Residence: 4747 Executive Drive, Suite 210, San Diego, CA 92121

(c). Citizenship

Item 2(c). Citizenship: Tang Capital Partners is a Delaware limited partnership. Tang Capital Management is a Delaware limited liability company. Mr. Tang is a United States citizen.

(d). Title of Class of Securities

Item 2(d). Title of Class of Securities: Common Stock, par value $0.000005 per share (the “Common Stock”)

(e). CUSIP Number 74019P108

Item 2(e). CUSIP Number 74019P108

Not applicable

Item 3. Not applicable.

Ownership

Item 4. Ownership. (a) Amount Beneficially Owned: Tang Capital Partners. Tang Capital Partners beneficially owns 6,400,000 of the Issuer’s Common Stock. Tang Capital Partners shares voting and dispositive power over such shares with Tang Capital Management and Kevin Tang. Tang Capital Management. Tang Capital Management beneficially owns 6,400,000 of the Issuer’s Common Stock. Tang Capital Management shares voting and dispositive power over such shares with Tang Capital Partners and Kevin Tang. Kevin Tang. Kevin Tang beneficially owns 6,400,000 of the Issuer’s Common Stock. Kevin Tang shares voting and dispositive power over such shares with Tang Capital Partners and Tang Capital Management. Page 5 of 8 pages The percentages used herein are based on 121,918,830 shares of Common Stock outstanding as of November 27, 2023, as set forth in the Issuer’s Proxy Statement filed on Schedule 14A that was filed with the Securities and Exchange Commission on December 4, 2023. (b) Percent of Class: Tang Capital Partners 5.2% Tang Capital Management 5.2% Kevin Tang 5.2% (c) Number of shares as to which such person has: (i) sole power to vote or to direct the vote: Tang Capital Partners 0 shares Tang Capital Management 0 shares Kevin Tang 0 shares (ii) shared power to vote or to direct the vote: Tang Capital Partners 6,400,000 shares Tang Capital Management 6,400,000 shares Kevin Tang 6,400,000 shares (iii) sole power to dispose or to direct the disposition of: Tang Capital Partners 0 shares Tang Capital Management 0 shares Kevin Tang 0 shares (iv) shared power to dispose or to direct the disposition of: Tang Capital Partners 6,400,000 shares Tang Capital Management 6,400,000 shares Kevin Tang 6,400,000 shares

Ownership of Five Percent or Less of a Class

Item 5. Ownership of Five Percent or Less of a Class. If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following: ¨

Ownership of More than Five Percent on Behalf of Another Person

Item 6. Ownership of More than Five Percent on Behalf of Another Person. Not applicable

Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the

Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company. Not applicable.

Identification and Classification of Members of the Group

Item 8. Identification and Classification of Members of the Group. Not applicable.

Notice of Dissolution of Group

Item 9. Notice of Dissolution of Group. Not applicable. Page 6 of 8 pages

Certification

Item 10. Certification. By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect. Page 7 of 8 pages Signature After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Date: February 5, 2024 TANG CAPITAL PARTNERS, LP By: Tang Capital Management, LLC, its General Partner By: /s/ Kevin Tang Kevin Tang, Manager TANG CAPITAL MANAGEMENT, LLC By: /s/ Kevin Tang Kevin Tang, Manager /s/ Kevin Tang Kevin Tang Page 8 of 8 pages

View Full Filing

View this SC 13G filing on SEC EDGAR